
Opinion|Videos|May 15, 2024
Key Findings from MAJIC-PV
A comprehensive overview of key findings from the MAJIC-PV trial investigating ruxolitinib in patients with polycythemia vera, highlighting efficacy and symptom improvement.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement















